
Επιλέξτε την ετικέτα σας
εμφανίζεται απευθείας στο φιαλίδιοΈκθεση εργαστηρίου
PDF- Ελέγχθηκε
- SLU-PP-332 Oral 5mg × 100 Tabs
- Εργαστήριο
- Analiza Białek
- Ημερομηνία
- August 2026
- Αποτέλεσμα
- 5.12 mg per tablet (5 mg label)
- Αρ. παραγγελίας
- Κωδικός πρόσβασης
Ελέγχθηκε ανεξάρτητα, επαληθεύσιμο με τον κωδικό πρόσβασης απευθείας στο εργαστήριο.
SLU-PP-332 Oral
Anti-Aging Oral
- Εργαστηριακά ελεγμένο
- Αποστολή από τη Γερμανία
Παραγγελία
- DHL με παρακολούθηση
- Διακριτική συσκευασία
Με μια ματιά
SLU-PP-332 Oral σε αριθμούς
Τα βασικά στοιχεία από το λεξικό μας.
Πλήρες λήμμα λεξικού- Class
- ERR agonistexercise mimetic
- Frequency
- Dailyrather in the morning
- Sizes
- 7 sizes250mcg*100tabs, 500mcg*100tabs, 1mg*100tabs …
What studies show
The source in the lexiconSynthetic ERR agonist alleviates metabolic syndrome (mouse model, preclinical) (opens in a new tab)
Billon et al., J. of Pharmacology and Experimental Therapeutics, 2024
Αξιολογήσεις
Τι λένε οι πελάτες
Μόνο πραγματικές παραγγελίες που περιείχαν SLU-PP-332 Oral.
Όλες οι αξιολογήσειςΓνώσεις
Όλα για το SLU-PP-332 Oral
Αναλυτικές πληροφορίες έρχονται σύντομα.
Are there studies in humans?
No. As of 26 October 2026 ClinicalTrials.gov lists no trial with SLU-PP-332 and ChEMBL lists it without a clinical phase. All data come from cell assays and mouse models.
What does SLU-PP-332 do in the cell?
It activates the three nuclear receptors ERRα, ERRβ and ERRγ, most strongly ERRα. These receptors switch on genes for mitochondria and fat burning. In muscle cells mitochondrial function and cellular respiration rose.
What did the mouse studies show?
Sedentary mice ran about 70 percent longer and 45 percent further after 7 days, the share of endurance muscle fibres rose. In obese mice energy use and fat burning rose, fat mass increased less and insulin action improved.
Does it work as a tablet too?
That has not been studied. In the endurance study SLU-PP-332 was injected into the abdominal cavity, two hours later its level was higher in muscle than in blood. There are no data on oral absorption in humans.
What about heart and kidney?
In a mouse model of pressure-overload heart failure SLU-PP-332 improved pumping function, reduced fibrosis and extended survival, mainly via ERRγ. In 21-month-old mice protein loss in urine and inflammation in the kidney fell after 8 weeks.
Which side effects are known?
There are no solid data because SLU-PP-332 has never been tested in humans. In mice no obvious toxicity appeared over 10 days. That does not rule out risks in humans.
Σχετικά προϊόντα
Σχετικά προϊόντα
SLU-PP-332 Oral